Gilles Andrier, CEO is interviewed by Givaudan employee Alice. They discuss how the business delivered in the first year of its new strategy cycle, while also managing through another pandemic year. wellbeing of our employees, ensuring we delivered for our customers, and overall remaining a resilient business. Across our growth drivers and enablers, we’ve been effectively implementing our strategy, and the key themes we identified have been strengthened and proven to be the right ones, such as health and wellbeing, naturals, plant-based proteins, Active Beauty among many others. I’d like to express my huge thanks and pride in all of our over 16,800 colleagues around the world who contributed to Givaudan’s success in 2021. A Ov erall, how did the business perform? GA Ambitious financial targets are central to our 2025 strategy roadmap, along with the addition of purpose-link ed targets to show the progress we want to make towards our longer- term purpose ambitions in the areas of Creations, Nature, People and Communities. We aim to achieve average organic sales growth of 4-5% on a like-for-like basis and an average free cash flow of at least 12%. We grew strongly in 2021, achieving sales of CHF 6,684 million, a growth of 7.1% and an average free cash flow of 12.6%. We showed once again our ability to deliver industry leading, purpose-led growth with a long-term perspective. All areas CEO INTERVIEW I am proud to look back at a year of great achievements, in pursuit of delivering sustainable value creation for all our stakeholders. Alice In 2021, we continued to face the challenges of the evolving pandemic. How would you characterise the year? Gill es Andrier Ov erall, it was a significant and strong year for us. Significant as we started out on our next five-year strategy cycle – ‘Committed to Growth, with Purpose’ – and delivered a strong financial performance while also making progress on our purpose targets. We also showed our strength in being able to deliver this against a backdrop of continuing challenges from the second year of the pandemic. We continued to prioritise the health and Givaudan – 2021 Integrated Annual Report 12 A year in review CE O interview